Drug Profile
Monoclonal antibody BW494
Latest Information Update: 16 Sep 1996
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pancreatic cancer
Most Recent Events
- 09 Sep 1996 New profile
- 09 Sep 1996 Discontinued-II for Pancreatic cancer in Germany (IV-infusion)
- 09 Sep 1996 Discontinued-II for Pancreatic cancer in Netherlands (IV-infusion)